Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Global Eagle Entertainment Inc. Warrant Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ENTWW / Global Eagle Entertainment Inc. Warrant getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ENTWW / Global Eagle Entertainment Inc. Warrant. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-29 | 2020-04-28 | 4 | Marks Joshua | ENT | Common Stock | D | 2,7000 | -622 | -2 | 50.610 | ||||
| 2020-03-30 | 2020-03-27 | 4 | Marks Joshua | ENT | Common Stock | D | 0,1600 | -103.775 | -17 | 1.280.817 | ||||
| 2020-03-30 | 2020-03-30 | 4 | Noren Per | ENT | Common Stock | D | 0,1700 | -11.448 | -2 | 624.508 | ||||
| 2020-03-30 | 2020-03-27 | 4 | Noren Per | ENT | Common Stock | D | 0,1600 | -49.416 | -8 | 635.956 | ||||
| 2020-03-30 | 2020-03-27 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 0,1600 | -24.708 | -4 | 1.204.810 | ||||
| 2020-02-25 | 2020-02-21 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 0,4100 | -19.766 | -8 | 1.229.518 | ||||
| 2019-11-22 | 2019-11-21 | 4 | Marks Joshua | ENT | Common Stock | D | 0,4479 | 20.000 | 9 | 1.384.592 | ||||
| 2019-08-28 | 2019-08-27 | 4 | Reding Robert W | ENT | Common Stock | D | 0,6100 | 25.000 | 15 | 143.033 | ||||
| 2019-08-21 | 2019-08-19 | 4 | Steger Ronald | ENT | Common Stock | D | 0,6600 | 50.000 | 33 | 309.379 | ||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 166.667 | ||||||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 208.333 | ||||||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 166.667 | ||||||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 166.667 | ||||||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 208.333 | ||||||||
| 2019-08-19 | 3 | Everett R. Jason | ENT | Common Stock | D | 208.333 | ||||||||
| 2019-08-15 | 2019-08-13 | 4 | Reding Robert W | ENT | Common Stock | D | 0,6400 | 25.000 | 16 | 118.033 | ||||
| 2019-06-26 | 2019-06-24 | 4 | Steger Ronald | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Zinterhofer Eric Louis | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Hasker Stephen | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Reding Robert W | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-26 | 2019-06-24 | 4 | SLOAN HARRY | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Sondag Eric | ENT | Stock Options (Right to Buy) | D | 0,65 | 37.736 | 37.736 | |||||
| 2019-06-13 | 2019-06-05 | 4 | Steger Ronald | ENT | Common Stock | D | 0,5100 | 50.000 | 26 | 259.379 | ||||
| 2019-06-13 | 2019-06-05 | 4 | Steger Ronald | ENT | Common Stock | D | 0,5000 | 150.000 | 75 | 209.379 | ||||
| 2019-06-11 | 2019-06-07 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 0,5400 | 400.000 | 216 | 1.249.284 | ||||
| 2019-06-07 | 2019-06-05 | 4 | Zinterhofer Eric Louis See below | ENT | Common Stock | I | 0,3000 | 5.000.000 | 1.500 | 6.941.707 | ||||
| 2019-06-07 | 2019-06-05 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 0,3000 | 5.000.000 | 1.500 | 6.941.707 | ||||
| 2019-06-06 | 2019-06-04 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Common Stock, par value $0.0001 per share | D | 0,2500 | -28.981.072 | -7.245 | 0 | ||||
| 2019-05-31 | 2019-05-29 | 4 | Reding Robert W | ENT | Common Stock | D | 0,7300 | 20.000 | 15 | 93.033 | ||||
| 2019-05-29 | 2019-05-24 | 4 | Searchlight II TBO-W, L.P. | ENT | 2.75% Convertible Senior Notes due 2035 | D | 2.000 | 3.000 | ||||||
| 2019-05-29 | 3 | Mezger Christian M | ENT | Common Stock | D | 750.000 | ||||||||
| 2019-05-29 | 3 | Mezger Christian M | ENT | Common Stock | D | 600.000 | ||||||||
| 2019-05-29 | 3 | Mezger Christian M | ENT | Common Stock | D | 750.000 | ||||||||
| 2019-05-29 | 3 | Mezger Christian M | ENT | Common Stock | D | 600.000 | ||||||||
| 2019-05-29 | 2019-05-24 | 4 | Zinterhofer Eric Louis See below | ENT | 2.75% Convertible Senior Notes due 2035 | I | 2.000 | 3.000 | ||||||
| 2019-05-28 | 2019-05-23 | 4 | Noren Per | ENT | Common Stock | D | 0,8500 | 6.012 | 5 | 685.372 | ||||
| 2019-05-22 | 2019-05-20 | 4 | Reding Robert W | ENT | Common Stock | D | 1,0000 | 25.000 | 25 | 73.033 | ||||
| 2019-05-22 | 2019-05-20 | 4 | SLOAN HARRY | ENT | Common Shares | D | 1,0300 | 5.200 | 5 | 653.229 | ||||
| 2019-05-21 | 2019-05-17 | 4 | LEDDY JEFFREY A Pamela W Leddy Living Trust | ENT | Common Stock | I | 1,1500 | 50.000 | 57 | 849.284 | ||||
| 2019-05-21 | 2019-05-17 | 4 | Marks Joshua | ENT | Common Stock | D | 1,0900 | 10.000 | 11 | 1.364.592 | ||||
| 2019-05-17 | 2019-05-15 | 4 | See Sarlina | ENT | Common Stock | D | 1,2700 | -2.019 | -3 | 144.976 | ||||
| 2018-08-07 | 2018-08-03 | 4 | Marks Joshua | ENT | Common Shares | D | 2,3100 | -3.956 | -9 | 1.354.592 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Ballas Stephen | ENT | Common Stock | D | 2,3400 | -8.000 | -19 | 287.034 | ||||
| 2018-06-27 | 2018-06-25 | 4 | Sondag Eric | ENT | Stock Options (Right to Buy) | D | 2,65 | 4.209 | 4.209 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Sondag Eric | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Zinterhofer Eric Louis | ENT | Stock Options (Right to Buy) | D | 2,65 | 4.209 | 4.209 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Zinterhofer Eric Louis | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Noren Per | ENT | Stock Option | D | 2,65 | 439.803 | 439.803 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Noren Per | ENT | Stock Option | D | 2,65 | 219.902 | 219.902 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Noren Per | ENT | Common Stock | D | 166.667 | 679.360 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Noren Per | ENT | Common Stock | D | 333.333 | 512.693 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Rainey Paul | ENT | Stock Option | D | 2,65 | 241.892 | 241.892 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Rainey Paul | ENT | Stock Option | D | 2,65 | 120.946 | 120.946 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Rainey Paul | ENT | Common Stock | D | 91.667 | 370.311 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Rainey Paul | ENT | Common Stock | D | 183.333 | 278.644 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | See Sarlina | ENT | Stock Option | D | 2,65 | 109.951 | 109.951 | |||||
| 2018-06-27 | 2018-06-25 | 4 | See Sarlina | ENT | Stock Option | D | 2,65 | 54.975 | 54.975 | |||||
| 2018-06-27 | 2018-06-25 | 4 | See Sarlina | ENT | Common Stock | D | 41.667 | 146.995 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | See Sarlina | ENT | Common Stock | D | 83.333 | 105.328 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Hasker Stephen | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Reding Robert W | ENT | Stock Option (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | SAGANSKY JEFFREY | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | SHAPIRO EDWARD | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | SLOAN HARRY | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Steger Ronald | ENT | Stock Options (Right to Buy) | D | 2,65 | 16.835 | 16.835 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Adepoju Wale | ENT | Stock Option | D | 2,65 | 175.921 | 175.921 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Adepoju Wale | ENT | Stock Option | D | 2,65 | 87.961 | 87.961 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Adepoju Wale | ENT | Common Stock | D | 66.667 | 434.667 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Adepoju Wale | ENT | Common Stock | D | 133.333 | 368.000 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Ballas Stephen | ENT | Stock Option | D | 2,65 | 175.921 | 175.921 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Ballas Stephen | ENT | Stock Option | D | 2,65 | 87.961 | 87.961 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Ballas Stephen | ENT | Common Stock | D | 66.667 | 295.034 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Ballas Stephen | ENT | Common Stock | D | 133.333 | 228.367 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | LEDDY JEFFREY A | ENT | Stock Option | D | 2,65 | 439.803 | 439.803 | |||||
| 2018-06-27 | 2018-06-25 | 4 | LEDDY JEFFREY A | ENT | Stock Option | D | 2,65 | 219.902 | 219.902 | |||||
| 2018-06-27 | 2018-06-25 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 166.667 | 799.284 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 333.333 | 632.617 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Marks Joshua | ENT | Stock Option | D | 2,65 | 923.587 | 923.587 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Marks Joshua | ENT | Stock Option | D | 2,65 | 461.794 | 461.794 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Marks Joshua | ENT | Common Stock | D | 350.000 | 1.358.548 | ||||||
| 2018-06-27 | 2018-06-25 | 4 | Marks Joshua | ENT | Common Stock | D | 700.000 | 1.008.548 | ||||||
| 2018-06-05 | 2018-06-01 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 2,3750 | 25.000 | 59 | 781.419 | ||||
| 2018-05-30 | 2018-05-25 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,9676 | 173.641 | 342 | 1.941.707 | ||||
| 2018-05-30 | 2018-05-25 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9676 | 173.641 | 342 | 1.941.707 | ||||
| 2018-05-30 | 2018-05-25 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9676 | 173.641 | 342 | 1.941.707 | ||||
| 2018-05-29 | 2018-05-24 | 4 | Marks Joshua | ENT | 2.75% Convertible Senior Notes due 2035 | D | 45 | 45 | ||||||
| 2018-05-25 | 2018-05-24 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,9600 | 30.290 | 59 | 1.768.066 | ||||
| 2018-05-25 | 2018-05-23 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,9136 | 90.382 | 173 | 1.737.776 | ||||
| 2018-05-25 | 2018-05-24 | 4 | Noren Per | ENT | Common Stock | D | 1,9600 | 5.713 | 11 | 179.360 | ||||
| 2018-05-25 | 2018-05-24 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9600 | 30.290 | 59 | 1.768.066 | ||||
| 2018-05-25 | 2018-05-23 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9136 | 90.382 | 173 | 1.737.776 | ||||
| 2018-05-25 | 2018-05-24 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9600 | 30.290 | 59 | 1.768.066 | ||||
| 2018-05-25 | 2018-05-23 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,9136 | 90.382 | 173 | 1.737.776 | ||||
| 2018-05-23 | 2018-05-22 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,8808 | 328.593 | 618 | 1.647.394 | ||||
| 2018-05-23 | 2018-05-21 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,7738 | 750.001 | 1.330 | 1.318.801 | ||||
| 2018-05-23 | 2018-05-22 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,8808 | 328.593 | 618 | 1.647.394 | ||||
| 2018-05-23 | 2018-05-21 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,7738 | 750.001 | 1.330 | 1.318.801 | ||||
| 2018-05-23 | 2018-05-22 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,8808 | 328.593 | 618 | 1.647.394 | ||||
| 2018-05-23 | 2018-05-21 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,7738 | 750.001 | 1.330 | 1.318.801 | ||||
| 2018-05-22 | 2018-05-18 | 4 | Marks Joshua | ENT | Common Stock | D | 1,2500 | 17.000 | 21 | 308.548 | ||||
| 2018-05-22 | 2018-05-21 | 4 | SLOAN HARRY | ENT | Common Stock | D | 1,5938 | 250.000 | 398 | 648.029 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Reding Robert W | ENT | Common Stock | D | 1,0000 | 3 | 0 | 48.033 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Steger Ronald | ENT | Common Stock | D | 1,0244 | 25.000 | 26 | 59.379 | ||||
| 2018-05-21 | 2018-05-18 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,2603 | 200.000 | 252 | 568.800 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Zinterhofer Eric Louis See Below | ENT | 2.75% Convertible Senior Notes due 2035 | I | 1.000 | 1.000 | ||||||
| 2018-05-21 | 2018-05-17 | 4 | Zinterhofer Eric Louis See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,1685 | 368.800 | 431 | 368.800 | ||||
| 2018-05-21 | 2018-05-18 | 4 | Noren Per | ENT | Common Stock | D | 1,3640 | 30.000 | 41 | 173.647 | ||||
| 2018-05-21 | 2018-05-18 | 4 | SHAPIRO EDWARD | ENT | Common Stock | D | 1,3581 | 100.000 | 136 | 148.030 | ||||
| 2018-05-21 | 2018-05-18 | 4 | SLOAN HARRY | ENT | Common Stock | D | 1,3811 | 250.000 | 345 | 398.029 | ||||
| 2018-05-21 | 2018-05-18 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,2603 | 200.000 | 252 | 568.800 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Sondag Eric See Below | ENT | 2.75% Convertible Senior Notes due 2035 | I | 1.000 | 1.000 | ||||||
| 2018-05-21 | 2018-05-17 | 4 | Sondag Eric See Below | ENT | Common Stock, par value $0.0001 per share | I | 1,1685 | 368.800 | 431 | 368.800 | ||||
| 2018-05-21 | 2018-05-18 | 4 | Adepoju Wale | ENT | Common Stock | D | 1,3689 | 18.500 | 25 | 234.667 | ||||
| 2018-05-21 | 2018-05-17 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 1,1469 | 88.000 | 101 | 299.284 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Marks Joshua | ENT | Common Stock | D | 1,0758 | 58.000 | 62 | 291.548 | ||||
| 2018-05-21 | 2018-05-18 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,2603 | 200.000 | 252 | 568.800 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Searchlight II TBO-W, L.P. | ENT | 2.75% Convertible Senior Notes due 2035 | D | 1.000 | 1.000 | ||||||
| 2018-05-21 | 2018-05-17 | 4 | Searchlight II TBO-W, L.P. | ENT | Common Stock, par value $0.0001 per share | D | 1,1685 | 368.800 | 431 | 368.800 | ||||
| 2018-05-16 | 2018-05-15 | 4 | See Sarlina | ENT | Common Stock | D | 0,8700 | -1.369 | -1 | 21.595 | ||||
| 2018-04-30 | 2018-04-28 | 4 | Adepoju Wale | ENT | Common Stock | D | 1,1700 | -16.918 | -20 | 216.167 | ||||
| 2018-04-30 | 2018-04-28 | 4 | Ballas Stephen | ENT | Common Stock | D | 1,1700 | -5.246 | -6 | 95.034 | ||||
| 2018-04-12 | 2018-04-11 | 4 | Ballas Stephen | ENT | Common Stock | D | 1,1300 | -4.919 | -6 | 100.280 | ||||
| 2018-04-09 | 3 | Noren Per | ENT | Common Stock | D | 287.294 | ||||||||
| 2018-04-09 | 3 | Noren Per | ENT | Common Stock | D | 287.294 | ||||||||
| 2018-04-09 | 3 | Noren Per | ENT | Common Stock | D | 287.294 | ||||||||
| 2018-04-05 | 2018-04-03 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 1,0900 | -19.872 | -22 | 191.412 | ||||
| 2018-04-04 | 2018-04-03 | 4 | Rainey Paul | ENT | Common Stock | D | 1,0900 | -5.935 | -6 | 95.311 | ||||
| 2018-03-26 | 2018-03-22 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6000 | -2.300 | -4 | 9.455.783 | ||||
| 2018-03-26 | 2018-03-21 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6023 | -22.746 | -36 | 9.458.083 | ||||
| 2018-03-21 | 2018-03-20 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6017 | -601 | -1 | 9.480.879 | ||||
| 2018-03-21 | 2018-03-19 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6011 | -39.453 | -63 | 9.481.480 | ||||
| 2018-03-19 | 2018-03-16 | 4 | Adepoju Wale | ENT | Common Stock | D | 1,6200 | -1.554 | -3 | 233.085 | ||||
| 2018-03-13 | 2018-03-09 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,7523 | -4.800 | -8 | 9.520.883 | ||||
| 2018-03-12 | 2018-03-10 | 4 | Adepoju Wale | ENT | Common Stock | D | 1,5900 | -2.254 | -4 | 234.639 | ||||
| 2018-03-08 | 2018-03-07 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6048 | -5.700 | -9 | 9.525.683 | ||||
| 2018-03-08 | 2018-03-06 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6213 | -23.243 | -38 | 9.531.383 | ||||
| 2018-02-28 | 2018-02-26 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6245 | -23.024 | -37 | 9.554.626 | ||||
| 2018-02-26 | 2018-02-23 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6131 | -10.305 | -17 | 9.577.650 | ||||
| 2018-02-26 | 2018-02-22 | 4 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock | I | 1,6959 | -50.000 | -85 | 9.587.955 | ||||
| 2017-12-26 | 2017-12-21 | 4 | Ballas Stephen | ENT | Common Stock | D | 62.305 | 105.199 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | LEDDY JEFFREY A | ENT | Stock Option Right to Buy | D | 6,22 | 350.000 | 1.000.000 | |||||
| 2017-12-26 | 2017-12-21 | 4 | LEDDY JEFFREY A | ENT | Stock Option Right to Buy | D | 6,22 | 650.000 | 650.000 | |||||
| 2017-12-26 | 2017-12-21 | 4 | LEDDY JEFFREY A | ENT | Stock Option Right to Buy | D | 3,21 | 5.029 | 5.029 | |||||
| 2017-12-26 | 2017-12-21 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 200.000 | 211.284 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 2.194 | 11.284 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Marks Joshua | ENT | Common Stock | D | 179.906 | 233.548 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Rainey Paul | ENT | Stock Options Right to Buy | D | 3,21 | 232.026 | 232.026 | |||||
| 2017-12-26 | 2017-12-21 | 4 | Rainey Paul | ENT | Common Stock | D | 101.246 | 101.246 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Reding Robert W | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | Reding Robert W | ENT | Common Stock | D | 31.152 | 48.030 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Reding Robert W | ENT | Common Stock | D | 7.788 | 16.878 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SAGANSKY JEFFREY | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 31.152 | 788.870 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 7.788 | 757.718 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | See Sarlina | ENT | Stock Option Right to Buy | D | 3,21 | 26.772 | 26.772 | |||||
| 2017-12-26 | 2017-12-21 | 4 | See Sarlina | ENT | Common Stock | D | 23.364 | 23.764 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SHAPIRO EDWARD | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | SHAPIRO EDWARD | ENT | Common Stock | D | 31.152 | 48.030 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SHAPIRO EDWARD | ENT | Common Stock | D | 7.788 | 16.878 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SLOAN HARRY | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | SLOAN HARRY | ENT | Common Stock | D | 31.152 | 148.029 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | SLOAN HARRY | ENT | Common Stock | D | 7.788 | 116.877 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Steger Ronald | ENT | Stock Option Right to Buy | D | 3,21 | 7.395 | 7.395 | |||||
| 2017-12-26 | 2017-12-21 | 4 | Steger Ronald | ENT | Common Stock | D | 31.152 | 34.379 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Steger Ronald | ENT | Common Stock | D | 3.227 | 3.227 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | EPSTEIN JEFFREY E | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | EPSTEIN JEFFREY E | ENT | Common Stock | D | 31.152 | 48.030 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | EPSTEIN JEFFREY E | ENT | Common Stock | D | 7.788 | 16.878 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Hasker Stephen | ENT | Stock Option Right to Buy | D | 3,21 | 17.848 | 17.848 | |||||
| 2017-12-26 | 2017-12-21 | 4 | Hasker Stephen | ENT | Common Stock | D | 31.152 | 47.109 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Hasker Stephen | ENT | Common Stock | D | 7.788 | 15.957 | ||||||
| 2017-12-26 | 2017-12-21 | 4 | Adepoju Wale | ENT | Common Stock | D | 200.236 | 236.893 | ||||||
| 2017-08-07 | 2017-08-03 | 4 | Marks Joshua | ENT | Common Stock | D | 3,0400 | -5.232 | -16 | 53.642 | ||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. By EMC Acquisition Holdings, LLC | ENT | Common Stock, $0.0001 par value per share | I | 14.718.004 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-07-31 | 3 | EMC HoldCo 2 B.V. | ENT | Common Stock, $0.0001 par value per share | D | 14.195.861 | ||||||||
| 2017-04-11 | 2017-04-11 | 4 | Ballas Stephen | ENT | Common Stock | D | 3,1300 | -5.240 | -16 | 42.894 | ||||
| 2017-03-17 | 2017-03-16 | 4 | Trosian Kevin | ENT | Common Stock | D | 4,0900 | -1.248 | -5 | 10.158 | ||||
| 2017-03-17 | 2017-03-16 | 4 | Chapelo Zant | ENT | Common Stock | D | 4,0900 | -905 | -4 | 28.332 | ||||
| 2017-03-17 | 2017-03-16 | 4 | Adepoju Wale | ENT | Common Stock | D | 4,0900 | -1.635 | -7 | 36.657 | ||||
| 2017-03-13 | 2017-03-10 | 4 | Chapelo Zant | ENT | Common Stock | D | 4,1100 | -1.319 | -5 | 29.237 | ||||
| 2017-03-13 | 2017-03-10 | 4 | Adepoju Wale | ENT | Common Stock | D | 4,1100 | -2.414 | -10 | 38.292 | ||||
| 2016-11-07 | 2016-11-03 | 4 | Mullen Frank | ENT | Stock Option (Right to Buy) | D | 7,65 | 68.225 | 68.225 | |||||
| 2016-11-07 | 2016-11-03 | 4 | Mullen Frank | ENT | Common Stock | D | 26.144 | 26.144 | ||||||
| 2016-10-13 | 2016-10-11 | 4 | Adepoju Wale | ENT | Stock Option (Right to Buy) | D | 9,21 | 90.340 | 90.340 | |||||
| 2016-08-26 | 2016-08-25 | 4 | SEVERSON THOMAS E JR | ENT | Stock Option (Right to Buy) | D | 8,41 | 200.000 | 200.000 | |||||
| 2016-08-26 | 2016-08-25 | 4 | SEVERSON THOMAS E JR | ENT | Common Stock | D | 80.000 | 80.000 | ||||||
| 2016-08-17 | 2016-08-16 | 4 | Chatterjee Aditya | ENT | Common Stock | D | 9,1900 | -3.129 | -29 | 4.278 | ||||
| 2016-08-04 | 2016-08-03 | 4 | Marks Joshua | ENT | Common Stock | D | 8,2200 | -6.126 | -50 | 58.874 | ||||
| 2016-07-28 | 2016-07-27 | 4 | Avellan Abel Antonio | ENT | Stock Option (Right to Buy) | D | 8,03 | 450.000 | 450.000 | |||||
| 2016-07-28 | 2016-07-27 | 4 | Avellan Abel Antonio | ENT | Common Stock | D | 8,0300 | -74.103 | -595 | 375.897 | ||||
| 2016-07-28 | 2016-07-27 | 4 | Avellan Abel Antonio | ENT | Common Stock | D | 175.000 | 450.000 | ||||||
| 2016-07-28 | 2016-07-27 | 4 | Avellan Abel Antonio | ENT | Common Stock | D | 275.000 | 275.000 | ||||||
| 2016-07-07 | 3 | Trosian Kevin | ENT | Common Stock | D | 22.814 | ||||||||
| 2016-07-07 | 3 | Trosian Kevin | ENT | Common Stock | D | 22.814 | ||||||||
| 2016-07-07 | 3 | Marks Joshua | ENT | Common Stock | D | 130.000 | ||||||||
| 2016-07-07 | 3 | Marks Joshua | ENT | Common Stock | D | 130.000 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 45.151 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 35.110 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 45.151 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 41.963 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 35.110 | ||||||||
| 2016-07-07 | 3 | Chapelo Zant | ENT | Common Stock | D | 41.963 | ||||||||
| 2016-05-13 | 2016-03-16 | 4 | DAVIS DAVID M | ENT | Common Stock | D | 8,2600 | -2.555 | -21 | 111.700 | ||||
| 2016-05-13 | 2016-03-16 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 8,2600 | -535 | -4 | 46.103 | ||||
| 2016-05-13 | 2015-09-17 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 11,9800 | -1.857 | -22 | 46.638 | ||||
| 2016-05-13 | 2016-03-16 | 4 | Itzkowitz Jay | ENT | Common Stock | D | 8,2600 | -524 | -4 | 902 | ||||
| 2016-05-13 | 2016-03-16 | 4 | Chatterjee Aditya | ENT | Common Stock | D | 8,2600 | -443 | -4 | 7.407 | ||||
| 2016-05-13 | 2015-09-17 | 4 | Chatterjee Aditya | ENT | Common Stock | D | 11,9800 | -1.227 | -15 | 7.850 | ||||
| 2016-05-13 | 2016-03-16 | 4 | Adepoju Wale | ENT | Common Stock | D | 8,2600 | -1.429 | -12 | 40.706 | ||||
| 2016-05-13 | 2015-09-17 | 4 | Adepoju Wale | ENT | Common Stock | D | 11,9800 | -2.880 | -35 | 42.135 | ||||
| 2016-04-13 | 2016-04-11 | 4 | Ballas Stephen | ENT | Stock Option (Right to Buy) | D | 8,44 | 135.321 | 135.321 | |||||
| 2016-04-13 | 2016-04-11 | 4 | Ballas Stephen | ENT | Common Stock | D | 48.105 | 48.105 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | SLOAN HARRY | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | SLOAN HARRY | ENT | Common Stock | D | 5.405 | 109.089 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | DAVIS DAVID M | ENT | Stock Option (Right to Buy) | D | 9,25 | 169.884 | 169.884 | |||||
| 2016-03-21 | 2016-03-10 | 4 | DAVIS DAVID M | ENT | Common Stock | D | 59.459 | 114.255 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | SHAPIRO EDWARD | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | SHAPIRO EDWARD | ENT | Common Stock | D | 5.405 | 9.090 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | LEDDY JEFFREY A | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 5.405 | 9.090 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | Reding Robert W | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | Reding Robert W | ENT | Common Stock | D | 5.405 | 9.090 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | EPSTEIN JEFFREY E | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | EPSTEIN JEFFREY E | ENT | Common Stock | D | 5.405 | 9.090 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | SAGANSKY JEFFREY | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 5.405 | 748.631 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 9,7600 | -1.421 | -14 | 743.226 | ||||
| 2016-03-21 | 2016-03-09 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 9,7500 | -51 | -0 | 744.647 | ||||
| 2016-03-21 | 2016-03-08 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 9,7500 | -2.504 | -24 | 744.698 | ||||
| 2016-03-21 | 2016-03-10 | 4 | Hasker Stephen | ENT | Stock Option (Right to Buy) | D | 9,25 | 15.444 | 15.444 | |||||
| 2016-03-21 | 2016-03-10 | 4 | Hasker Stephen | ENT | Common Stock | D | 5.405 | 8.169 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | Zemetra Michael Leonard | ENT | Stock Option (Right to Buy) | D | 9,25 | 54.054 | 54.054 | |||||
| 2016-03-21 | 2016-03-10 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 18.919 | 48.495 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | Itzkowitz Jay | ENT | Stock Option (Right to Buy) | D | 9,25 | 47.876 | 47.876 | |||||
| 2016-03-21 | 2016-03-10 | 4 | Itzkowitz Jay | ENT | Common Stock | D | 16.757 | 22.460 | ||||||
| 2016-03-21 | 2016-03-10 | 4 | Adepoju Wale | ENT | Stock Option (Right to Buy) | D | 9,25 | 63.012 | 63.012 | |||||
| 2016-03-21 | 2016-03-10 | 4 | Adepoju Wale | ENT | Common Stock | D | 22.054 | 45.015 | ||||||
| 2015-11-04 | 2015-11-02 | 4 | Itzkowitz Jay | ENT | Common Stock | D | 13,0041 | -2.238 | -29 | 5.703 | ||||
| 2015-11-04 | 2015-11-02 | 4 | Itzkowitz Jay | ENT | Common Stock | D | 13,0041 | -3.770 | -49 | 7.941 | ||||
| 2015-05-12 | 3 | Adepoju Wale | ENT | Common Stock | D | 38.170 | ||||||||
| 2015-05-12 | 3 | Adepoju Wale | ENT | Common Stock | D | 38.170 | ||||||||
| 2015-05-12 | 3 | Adepoju Wale | ENT | Common Stock | D | 30.713 | ||||||||
| 2015-05-12 | 3 | Adepoju Wale | ENT | Common Stock | D | 30.713 | ||||||||
| 2015-05-11 | 3 | Chatterjee Aditya | ENT | Common Stock | D | 14.779 | ||||||||
| 2015-05-11 | 3 | Chatterjee Aditya | ENT | Common Stock | D | 12.449 | ||||||||
| 2015-05-11 | 3 | Chatterjee Aditya | ENT | Common Stock | D | 14.779 | ||||||||
| 2015-05-11 | 3 | Chatterjee Aditya | ENT | Common Stock | D | 12.449 | ||||||||
| 2015-05-11 | 3 | Itzkowitz Jay | ENT | Common Stock | D | 17.414 | ||||||||
| 2015-05-11 | 3 | Itzkowitz Jay | ENT | Common Stock | D | 17.414 | ||||||||
| 2015-05-11 | 3 | Itzkowitz Jay | ENT | Common Stock | D | 17.719 | ||||||||
| 2015-05-11 | 3 | Itzkowitz Jay | ENT | Common Stock | D | 17.719 | ||||||||
| 2015-05-04 | 2015-04-30 | 4 | SHAPIRO EDWARD | ENT | Common Stock | D | 3.685 | 3.685 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | DAVIS DAVID M | ENT | Stock Option (Right to Buy) | D | 13,15 | 84.268 | 84.268 | |||||
| 2015-05-01 | 2015-03-16 | 4 | DAVIS DAVID M | ENT | Common Stock | D | 29.477 | 53.855 | ||||||
| 2015-05-01 | 2015-04-30 | 4 | EPSTEIN JEFFREY E | ENT | Common Stock | D | 3.685 | 3.685 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | EPSTEIN JEFFREY E | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-05-01 | 2015-03-16 | 4 | EPSTEIN JEFFREY E | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2015-04-30 | 4 | LEDDY JEFFREY A | ENT | Common Stock | D | 3.685 | 3.685 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | LEDDY JEFFREY A | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-05-01 | 2015-03-16 | 4 | LEDDY JEFFREY A | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2015-04-30 | 4 | Reding Robert W | ENT | Common Stock | D | 3.685 | 3.685 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | Reding Robert W | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-05-01 | 2015-03-16 | 4 | Reding Robert W | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2015-04-30 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 3.685 | 747.202 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | SAGANSKY JEFFREY | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.553 | |||||
| 2015-05-01 | 2015-03-16 | 4 | SAGANSKY JEFFREY | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2014-05-07 | 4 | SAGANSKY JEFFREY | ENT | Sponsor Warrants | D | 11,50 | -3.900 | 0 | |||||
| 2015-05-01 | 2015-04-30 | 4 | SLOAN HARRY | ENT | Common Stock | D | 3.685 | 103.684 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | SLOAN HARRY | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-05-01 | 2015-03-16 | 4 | SLOAN HARRY | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2015-04-30 | 4 | Belanger-Martin Louis | ENT | Common Stock | D | 3.685 | 107.662 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | Belanger-Martin Louis | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-05-01 | 2015-03-16 | 4 | Belanger-Martin Louis | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-05-01 | 2015-04-30 | 4 | Hasker Stephen | ENT | Stock Option (Right to Buy) | D | 12,77 | 7.900 | 7.900 | |||||
| 2015-05-01 | 2015-04-30 | 4 | Hasker Stephen | ENT | Common Stock | D | 2.764 | 2.764 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | Zemetra Michael Leonard | ENT | Option (right to buy) | D | 13,15 | 15.800 | 15.800 | |||||
| 2015-05-01 | 2015-03-16 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 4.942 | 29.400 | ||||||
| 2015-05-01 | 2015-03-16 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 5.527 | 24.458 | ||||||
| 2015-05-01 | 2015-01-30 | 4 | Zemetra Michael Leonard | ENT | Option (right to buy) | D | 9,87 | -4.896 | 181.979 | |||||
| 2015-05-01 | 2015-01-30 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 15,4200 | -4.017 | -62 | 18.931 | ||||
| 2015-05-01 | 2015-01-30 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 9,8700 | 4.896 | 48 | 22.948 | ||||
| 2015-05-01 | 2015-01-21 | 4 | Zemetra Michael Leonard | ENT | Option (right to buy) | D | 9,87 | -87.999 | 186.875 | |||||
| 2015-05-01 | 2015-01-21 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 15,0000 | -69.973 | -1.050 | 18.052 | ||||
| 2015-05-01 | 2015-01-21 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 9,8700 | 87.999 | 869 | 88.025 | ||||
| 2015-05-01 | 2015-01-20 | 4 | Zemetra Michael Leonard | ENT | Option (right to buy) | D | 9,87 | -126 | 274.874 | |||||
| 2015-05-01 | 2015-01-20 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 15,0000 | -100 | -2 | 26 | ||||
| 2015-05-01 | 2015-01-20 | 4 | Zemetra Michael Leonard | ENT | Common Stock | D | 9,8700 | 126 | 1 | 126 | ||||
| 2015-04-21 | 2015-03-16 | 4 | SHAPIRO EDWARD | ENT | Stock Option (Right to Buy) | D | 13,15 | 10.533 | 10.533 | |||||
| 2015-04-21 | 2015-03-16 | 4 | SHAPIRO EDWARD | ENT | Stock Option (Right to Buy) | D | 13,15 | 21.067 | 21.067 | |||||
| 2015-04-13 | 3 | Hasker Stephen | ENT | No securities beneficially owned. | D | 0 | ||||||||
| 2015-02-20 | 2015-02-18 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 13,0990 | -800.000 | -10.479 | 744.816 | ||||
| 2015-01-09 | 2014-12-29 | 4 | SLOAN HARRY | ENT | Common Stock | D | -200.000 | 100.000 | ||||||
| 2015-01-09 | 2014-12-09 | 4 | SLOAN HARRY | ENT | Common Stock | D | -4.422.560 | 300.000 | ||||||
| 2015-01-08 | 2014-12-08 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | -29.370 | 1.544.816 | ||||||
| 2014-12-22 | 2014-12-19 | 4 | DAVIS DAVID M | ENT | Common Stock | D | 13,4031 | 5.000 | 67 | 24.122 | ||||
| 2014-11-10 | 2014-10-31 | 4 | Zemetra Michael Leonard | ENT | Employee Stock Option (right to buy Common Stock) | D | 12,23 | 75.000 | 75.000 | |||||
| 2014-09-15 | 2014-09-11 | 4 | SAGANSKY JEFFREY | ENT | Sponsor Warrants | D | -1.760.000 | 0 | ||||||
| 2014-09-15 | 2014-09-11 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | D | 586.608 | 1.574.186 | ||||||
| 2014-09-15 | 2014-09-11 | 4 | SLOAN HARRY | ENT | Sponsor Warrants | D | -5.280.001 | 0 | ||||||
| 2014-09-15 | 2014-09-11 | 4 | SLOAN HARRY | ENT | Common Stock | D | 1.759.824 | 4.722.559 | ||||||
| 2014-08-29 | 2014-08-27 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Common Stock, par value $0.0001 per share | I | 12.572 | 29.490.583 | ||||||
| 2014-08-29 | 2014-08-27 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Common Stock, par value $0.0001 per share | D | 12.572 | 29.490.583 | ||||||
| 2014-08-26 | 2014-08-22 | 4 | DAVIS DAVID M | ENT | Common Stock | D | 31 | 19.122 | ||||||
| 2014-07-11 | 2014-07-09 | 4 | DAVIS DAVID M | ENT | Option (right to buy) | D | 11,43 | 100.000 | 100.000 | |||||
| 2014-06-19 | 2014-06-17 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Non-Voting Common Stock, par value $0.0001 per share | D | -19.118.233 | 0 | ||||||
| 2014-06-19 | 2014-06-17 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Common Stock, par value $0.0001 per share | D | 19.118.233 | 28.492.985 | ||||||
| 2014-06-19 | 2014-06-17 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Non-Voting Common Stock, par value $0.0001 per share | I | -19.118.233 | 0 | ||||||
| 2014-06-19 | 2014-06-17 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Common Stock, par value $0.0001 per share | I | 19.118.233 | 28.492.985 | ||||||
| 2014-01-15 | 2014-01-13 | 4 | DAVIS DAVID M | ENT | Option to Purchase Common Stock | D | 16,70 | 25.000 | 25.000 | |||||
| 2014-01-03 | 2014-01-03 | 4 | SAGANSKY JEFFREY | ENT | Common Stock | I | -4.114.909 | 0 | ||||||
| 2014-01-03 | 2014-01-03 | 4 | Global Eagle Acquisition LLC | ENT | Common Stock | D | -4.114.909 | 0 | ||||||
| 2014-01-03 | 2014-01-03 | 4 | SLOAN HARRY | ENT | Common Stock | I | -4.114.909 | 0 | ||||||
| 2013-12-30 | 2013-12-28 | 4 | Belanger-Martin Louis | ENT | Option (right to buy) | D | 10,00 | -350.000 | 0 | |||||
| 2013-12-30 | 2013-12-28 | 4 | Belanger-Martin Louis | ENT | Common Stock | D | 103.977 | 103.977 | ||||||
| 2013-12-24 | 2013-12-20 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Convertible Promissory Note | I | -2.263.595 | 19.118.233 | ||||||
| 2013-12-24 | 2013-12-20 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Convertible Promissory Note | D | -2.263.595 | 19.118.233 | ||||||
| 2013-10-23 | 2013-10-21 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Convertible Promissory Note | I | 2.263.595 | 21.381.828 | ||||||
| 2013-10-23 | 2013-10-21 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Convertible Promissory Note | D | 2.263.595 | 21.381.828 | ||||||
| 2013-10-03 | 2013-10-02 | 4 | Belanger-Martin Louis | ENT | Option (right to buy) | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-10-03 | 2013-10-02 | 4 | Belanger-Martin Louis | ENT | Option (right to buy) | D | 10,00 | -400.000 | 350.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | LaValle John William | ENT | Common Stock, par value $0.0001 per share | D | 11,2500 | -36.814 | -414 | 217.022 | ||||
| 2013-04-04 | 2013-04-04 | 4 | SLOAN HARRY By Global Eagle Acquisition LLC | ENT | Sponsor Warrants | I | 11,50 | -7.333.334 | 0 | |||||
| 2013-04-04 | 2013-04-04 | 4 | SAGANSKY JEFFREY By Global Eagle Acquisition LLC | ENT | Sponsor Warrants | I | 11,50 | -7.333.334 | 0 | |||||
| 2013-04-04 | 2013-04-04 | 4 | Global Eagle Acquisition LLC | ENT | Sponsor Warrants | D | 11,50 | -7.333.334 | 0 | |||||
| 2013-02-20 | 2013-02-19 | 4 | SHAPIRO EDWARD | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-19 | 2013-02-19 | 4 | SAGANSKY JEFFREY | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-19 | 2013-02-19 | 4 | SLOAN HARRY | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-19 | 2013-02-19 | 4 | Reding Robert W | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-19 | 2013-02-19 | 4 | LEDDY JEFFREY A | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-19 | 2013-02-19 | 4 | EPSTEIN JEFFREY E | ENT | Option to Purchase Common Stock | D | 10,00 | 25.000 | 25.000 | |||||
| 2013-02-07 | 3 | Reding Robert W | ENT | No securities beneficially owned. | D | 0 | ||||||||
| 2013-02-01 | 3 | LEDDY JEFFREY A | ENT | No securities beneficially owned. | D | 0 | ||||||||
| 2013-02-01 | 3 | EPSTEIN JEFFREY E | ENT | No securities beneficially owned. | D | 0 | ||||||||
| 2013-02-01 | 3 | DAVIS DAVID M | ENT | Comon Stock, par value $0.0001 per share | D | 19.091 | ||||||||
| 2013-02-01 | 2013-01-31 | 4 | DAVIS DAVID M | ENT | Option to Purchase Common Stock | D | 10,00 | 675.000 | 675.000 | |||||
| 2013-02-01 | 2013-01-31 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Warrant (right to buy) | D | 32.199 | 32.199 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Warrant (right to buy) | D | 477.393 | 477.393 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Non-voting common stock, par value $0.0001 per share | D | 19.118.233 | 19.118.233 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | PAR INVESTMENT PARTNERS LP | ENT | Common stock, par value $0.0001 per share | D | 9.850.266 | 9.850.266 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | SLOAN HARRY | ENT | Sponsor Warrants | I | 11,50 | 0,7499 | 666.667 | 500 | 7.333.334 | |||
| 2013-02-01 | 2013-01-31 | 4 | SAGANSKY JEFFREY | ENT | Sponsor Warrants | I | 11,50 | 0,7499 | 666.667 | 500 | 7.333.334 | |||
| 2013-02-01 | 2013-01-31 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Warrant (right to buy) | I | -32.199 | 32.199 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Warrant (right to buy) | I | -477.393 | 477.393 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Non-voting common stock, par value $0.0001 per share | I | -19.118.233 | 19.118.233 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | SHAPIRO EDWARD See Footnotes | ENT | Common stock, par value $0.0001 per share | I | 9.850.266 | 9.850.266 | ||||||
| 2013-02-01 | 2013-01-31 | 4 | Global Eagle Acquisition LLC | ENT | Sponsor Warrants | D | 11,50 | 0,7499 | 666.667 | 500 | 7.333.334 | |||
| 2013-02-01 | 3 | Belanger-Martin Louis | ENT | No securities beneficially owned. | D | 0 | ||||||||
| 2013-02-01 | 2013-01-31 | 4 | Belanger-Martin Louis | ENT | Option to Purchase Common Stock | D | 10,00 | 750.000 | 750.000 | |||||
| 2013-02-01 | 2013-01-31 | 4 | LaValle John William | ENT | Option to Purchase Common Stock | D | 10,00 | 750.000 | 750.000 | |||||
| 2013-02-01 | 3 | LaValle John William | ENT | Common Stock, par value $0.0001 per share | D | 253.836 | ||||||||
| 2012-05-08 | 2012-05-08 | 4 | SAGANSKY JEFFREY | EAGL | Common Stock, par value $0.0001 per share | I | 0,0113 | -10.000 | -0 | 4.114.909 | ||||
| 2012-05-08 | 2012-05-08 | 4 | SLOAN HARRY | EAGL | Common Stock, par value $0.0001 per share | I | 0,0113 | -10.000 | -0 | 4.114.909 | ||||
| 2012-05-08 | 2012-05-08 | 4 | Global Eagle Acquisition LLC | EAGL | Common Stock, par value $0.0001 per share | D | 0,0113 | -10.000 | -0 | 4.114.909 | ||||
| 2012-05-08 | 2012-05-08 | 4 | Graf James A | EAGL | Common Stock, par value $0.0001 per share | I | 0,0113 | -400 | -0 | 164.596 | ||||
| 2012-05-08 | 3 | Sirucek Cole A. | EAGL | No Securities Beneficially Owned | D | 0 | ||||||||
| 2012-05-08 | 2012-05-08 | 4 | Sirucek Cole A. | EAGL | Common Stock, par value $0.0001 per share | D | 0,0113 | 10.000 | 0 | 10.000 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
